Find the right fit for you - faster
Get tailored insights about working at Elekta in one quick step.
Elekta Snapshot
Our vision is a world where everyone has access to the best cancer care.
Cancer is expected to grow twice as quickly as other diseases. It's likely to become the leading cause of death globally in a few decades, and expected to reach 23 million new cases in 2030. The challenge is real and we have an important part to play.
Our purpose is hope for everyone dealing with cancer.
Our mission is to improve patient lives by working together with our customers. We use our precision radiation expertise to work hand in hand with clinicians and our partners to continuously develop innovative, outcome-driven and cost-efficient solutions that provide lasting clinical difference. We believe in taking an open and proactive approach in our practices, enabling us to build strong partnerships and meet evolving patient needs, no matter where they are in the world. We don’t just build technology; we build hope.
Cancer is expected to grow twice as quickly as other diseases. It's likely to become the leading cause of death globally in a few decades, and expected to reach 23 million new cases in 2030. The challenge is real and we have an important part to play.
Our purpose is hope for everyone dealing with cancer.
Our mission is to improve patient lives by working together with our customers. We use our precision radiation expertise to work hand in hand with clinicians and our partners to continuously develop innovative, outcome-driven and cost-efficient solutions that provide lasting clinical difference. We believe in taking an open and proactive approach in our practices, enabling us to build strong partnerships and meet evolving patient needs, no matter where they are in the world. We don’t just build technology; we build hope.
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com
